Related Experiment Video

Updated: May 14, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor

Georgialina Rodriguez1, Jeremy A Ross, Zsuzsanna S Nagy

  • 1Department of Biological Sciences, The University of Texas at El Paso, El Paso, Texas 79902, USA.

The Journal of Biological Chemistry
|January 24, 2013
PubMed

Insights

Forskolin (Fsk) inhibits T-cell proliferation by disrupting Interleukin-2 (IL-2) signaling. This cyclic adenosine monophosphate (cAMP) activator impairs Janus kinase 3 (Jak3) and Signal transducer and activator of transcription 5 (Stat5) activation, crucial for T-cell function.

Area of Science:

  • Immunology
  • Cell Signaling
  • Molecular Biology

Background:

  • T-cell activity is regulated by cytokine signaling through complex pathways.
  • Understanding cross-talk between signaling pathways is key to T-cell function and dysfunction.

Purpose of the Study:

  • To investigate the cross-talk between Janus kinase 3/Signal transducer and activator of transcription 5 (Jak3/Stat5) and cyclic adenosine monophosphate (cAMP) signaling cascades.
  • To elucidate the inhibitory mechanism of Forskolin (Fsk) on T-cell proliferation and Interleukin-2 (IL-2) signaling.

Main Methods:

  • Treatment of human T-cells (MT-2 and Kit 225) with Forskolin (Fsk).
  • Analysis of IL-2 receptor complex formation, Jak3 activation, and Stat5 phosphorylation, nuclear translocation, and DNA binding.
  • In vitro kinase assays and small molecule inhibition studies to assess the role of Protein Kinase A (PKA).

Main Results:

  • Fsk increased intracellular cAMP levels, reduced T-cell proliferation by inhibiting cell cycle genes without inducing apoptosis.
  • Fsk inhibited IL-2-induced Stat5 phosphorylation, nuclear translocation, and DNA binding.
  • Fsk treatment disrupted IL-2 receptor complex formation and blocked Jak3 activation, with elevated serine phosphorylation of Jak3, suggesting PKA-mediated inactivation.

Conclusions:

  • Forskolin (Fsk) activation of adenylate cyclase and Protein Kinase A (PKA) negatively regulates IL-2 signaling.
  • Inhibition occurs at multiple levels, including Interleukin-2 receptor (IL-2R) complex formation and Jak3/Stat5 activation.
  • This study reveals a novel cross-talk mechanism impacting T-cell signaling and proliferation.

More Related Videos

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...